Cargando…
Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations
PURPOSE: The activation of the mitogen-activated protein kinase (MAPK) pathway has been suggested as the major downstream target when GNAQ and GNA11 (GNAQ/11) are mutated in uveal melanoma (UM). However, clinical trials with single agent MEK inhibitor showed no clinical significance in altering the...
Autores principales: | Boru, Getachew, Cebulla, Colleen M., Sample, Klarke M., Massengill, James B., Davidorf, Frederick H., Abdel-Rahman, Mohamed H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557618/ https://www.ncbi.nlm.nih.gov/pubmed/31173078 http://dx.doi.org/10.1167/iovs.18-26452 |
Ejemplares similares
-
Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese
por: Xu, Xiaolin, et al.
Publicado: (2014) -
Mutation spectrum in GNAQ and GNA11 in Chinese uveal melanoma
por: Zhang, Edward D, et al.
Publicado: (2019) -
BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi
por: Francis, Jasmine H., et al.
Publicado: (2018) -
Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
por: Koopmans, A E, et al.
Publicado: (2013) -
YAP inhibition blocks uveal melanogenesis driven by GNAQ or GNA11 mutations
por: Lyubasyuk, Vera, et al.
Publicado: (2014)